We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

164 hedge funds and large institutions have $1.49B invested in Ironwood Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 61 increasing their positions, 36 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 36

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

31% more call options, than puts

Call options by funds: $7.83M | Put options by funds: $5.96M

8% more funds holding

Funds holding: 152 → 164 (+12)

7.38% more ownership

Funds ownership: 103.66% → 111.03% (+7.4%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

15% less capital invested

Capital invested by funds: $1.76B → $1.49B (-$273M)

Holders
164
Holders Change
+12
Holders Change %
+7.89%
% of All Funds
3.6%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
33
Increased
61
Reduced
36
Closed
20
Calls
$7.83M
Puts
$5.96M
Net Calls
+$1.87M
Net Calls Change
-$693K

Top Buyers

Rank Fund Capital Flow
1
BCM
Brown Capital Management
Maryland
+$54.4M
2
MP
MFN Partners
Massachusetts
+$14.6M
3
CS
Credit Suisse
Switzerland
+$13.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$11.1M
5
Marshall Wace
Marshall Wace
United Kingdom
+$9.96M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$23.4M
2
Citadel Advisors
Citadel Advisors
Florida
-$15.3M
3
OM
Opaleye Management
Massachusetts
-$5.75M
4
HM
HealthCor Management
New York
-$5.47M
5
FI
Fosun International
China
-$4.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$8.85M +$6.31M +649,831 +170%
N
27
Nuveen
North Carolina
$8.74M +$895K +92,092 +10%
Charles Schwab
28
Charles Schwab
California
$8.03M +$283K +29,113 +3%
UBS Group
29
UBS Group
Switzerland
$8.03M +$4.99M +513,070 +121%
Bank of America
30
Bank of America
North Carolina
$6.35M +$1.58M +162,948 +28%
AI
31
Atom Investors
Texas
$5.9M +$6.68M +686,954 New
Invesco
32
Invesco
Georgia
$5.88M +$6.65M +684,378 New
Adage Capital Partners
33
Adage Capital Partners
Massachusetts
$5.79M – – –
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$5.74M +$301K +30,942 +5%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$5.72M +$153K +15,782 +2%
BCPEMI
36
Bain Capital Public Equity Management II
Massachusetts
$5.13M -$2.03M -208,550 -26%
Deutsche Bank
37
Deutsche Bank
Germany
$4.9M -$439K -45,212 -7%
Jacobs Levy Equity Management
38
Jacobs Levy Equity Management
New Jersey
$4.9M +$611K +62,900 +12%
CG
39
Colony Group
Massachusetts
$4.42M +$5M +515,012 New
1M
40
13D Management
New York
$4.4M +$227K +23,385 +5%
Two Sigma Investments
41
Two Sigma Investments
New York
$4.26M +$2.62M +269,297 +119%
PAM
42
Panagora Asset Management
Massachusetts
$3.45M +$88.6K +9,117 +2%
Squarepoint
43
Squarepoint
New York
$3.41M +$3.86M +396,739 New
CEP
44
Chicago Equity Partners
Illinois
$3.3M -$14K -1,445 -0.4%
American Century Companies
45
American Century Companies
Missouri
$2.85M +$410K +42,211 +15%
BCB
46
Brian C. Broderick
$2.78M -$52.1K -5,361 -2%
Two Sigma Advisers
47
Two Sigma Advisers
New York
$2.75M -$4.86K -500 -0.2%
Wells Fargo
48
Wells Fargo
California
$2.54M +$197K +20,275 +7%
Swiss National Bank
49
Swiss National Bank
Switzerland
$2.51M +$41.8K +4,300 +1%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$2.44M +$530K +54,536 +24%
1
2
3 4 5

IRWD Hedge Fund Activity: Q3 2019 in Review

164 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2019, worth a combined $1.49B — down 15% from $1.76B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new IRWD positions and 20 closed out — a net gain of 13 holders — while 61 added to existing stakes and 36 trimmed.

The largest buyer was Brown Capital Management, adding an estimated $54.4M. The largest seller was Fidelity Investments, cutting an estimated $23.4M.

  • 164 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2019, up from 152 in Q2 2019.
  • Funds reported $1.49B of Ironwood Pharmaceuticals stock for Q3 2019, down 15% quarter-over-quarter.
  • 33 funds opened new Ironwood Pharmaceuticals positions in Q3 2019 and 20 closed out, a net change of +13 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2019 was Brown Capital Management, an estimated $54.4M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2019 was Fidelity Investments, an estimated $23.4M sold.

Based on aggregated 13F filings for Q3 2019.